The Government Stopped Checking Whether Insurers Follow the Parity Law. It Just Said, Carefully, That It's Watching Again.
A year after suspending enforcement, the Department of Labor issued an interim roadmap for policing how insurers limit mental health and addiction coverage.
If an insurer has ever made you fight for a prior authorization on residential treatment, or bounced you between three case managers before approving a therapy referral, this week’s news is about the rule that’s supposed to stop exactly that — and about how long it’s been unenforced.
The Department of Labor’s Employee Benefits Security Administration suspended active enforcement of the Mental Health Parity and Addiction Equity Act’s toughest provision in 2025. On September 8, Assistant Secretary Daniel Aronowitz issued a bulletin describing an interim roadmap for re-enforcing it: the requirement that health plans document, through formal comparative analyses, that “nonquantitative treatment limitations” — prior authorization, medical necessity criteria, provider-network adequacy standards, the everyday administrative friction of getting care approved — aren’t applied more restrictively to mental health and substance use disorder benefits than to physical health benefits.
Aronowitz’s own framing of the pause matters as much as the bulletin itself: the agency, he said, had heard that its prior enforcement approach “created substantial confusion and unnecessary burdens on health plans” — language that reads, to a provider who’s been navigating a denial backlog for a year, less like a fix than like an explanation for why the fix was delayed. The bulletin is explicitly interim, covering where EBSA plans to focus in the meantime — the everyday NQTLs listed above — while a fuller rulemaking revising the MHPAEA regulations is still expected before the end of 2026. Nothing about the underlying law changed. What changed is whether anyone at the federal level was checking whether insurers followed it, and for roughly a year, the honest answer was: not actively.
For a treatment provider or case manager, the useful move this week isn’t waiting on the final rule — it’s starting to log every NQTL-shaped denial now: every prior-authorization delay, every “not medically necessary” reversal, every network gap that took weeks to route around. A comparative-analysis requirement that isn’t actively enforced still creates a paper trail an enforced version can use once EBSA’s roadmap turns into actual audits. Insurers know an enforcement pause when they see one; so should the people documenting what happened during it.
If you’ve spent the past year getting bounced between denials and appeals for coverage that was supposed to be guaranteed by law, this bulletin doesn’t undo that year. It’s the government admitting, in bureaucratic language, that the year happened. The provisions didn’t disappear during the pause. The willingness to check them did — and this bulletin is the government saying, carefully, that the checking is coming back.
Sources Cited
- 01.CTrump Administration Issues Interim Enforcement Roadmap for Mental Health Parity LawBehavioral Health Business
- 02.CTrump Administration Issues Interim Enforcement Roadmap for Mental Health Parity Law (mirror)Behavioral Healthcare Network
Filed Under
policytreatment
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The DEA Just Registered 900 Dispensaries. Nobody Registered a Plan for the Patient.
DOJ announced federal DEA registration for 900+ medical cannabis dispensaries in seven states, while refusing a Minnesota dual-licensed shop. What the implementation gates mean for providers.
Policy & FundingMarijuana Arrests Rose for the First Time in a Decade, and Almost All of the Increase Was Black
FWD.us reports cannabis possession arrests rose in 2025 for the first time in at least a decade. What the 83% and 45% figures actually measure, and what case managers and treatment intake teams can do with a pending charge.
Policy & FundingThe FDA Says Zyn Is Safer Than a Cigarette. It Left the Hard Part Off the Label.
The FDA's June 2026 modified-risk order lets 20 Zyn pouches claim lower disease risk than cigarettes. It says nothing about dependence, quitting, or the teenagers using the brand most.